Express Scripts (ESRX) 68.52 $ESRX
Earnings Look Back: Express Scripts Is Down 4.5% Since Reporting Quarterly Results 1 Week Ago (ESRX)
Comtex SmarTrend(R) - Mon May 12, 12:09PM CDT
When Express Scripts (NASDAQ:ESRX) reported earnings 13 days ago on April 29th, 2014, analysts, on average, expected the company to report earnings of $1.00 on sales of $23.8 billion. The company actually reported EPS of $0.99 on sales of $23.7 billion, missing EPS estimates by $0.01 and missing revenue estimates by $140.9 million. Since the company's report, shares of Express Scripts have fallen from $71.01 to $67.80, representing a loss of 4.5% in the past 13 days.
Watch for Express Scripts to Potentially Pullback After Gaining 1.13% Yesterday
Comtex SmarTrend(R) - Fri May 09, 3:52PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $66.71 to a high of $67.85. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.50 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.13% Gain
Comtex SmarTrend(R) - Fri May 09, 3:52PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $66.71 to a high of $67.85. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.50 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Critical Alerts For Philip Morris International, Coach, Express Scripts, Staples, and Splunk Released By InvestorsObserver
PR Newswire - Fri May 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PM, COH, ESRX, SPLS, and SPLK.
Earnings Releases, Dividends Announcements, and Product Improvements - Analyst Notes on Express Scripts, Humana, Endo, Incyte and Citrix
PR Newswire - Thu May 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Express Scripts Holding Company (NASDAQ: ESRX), Humana Inc. (NYSE: HUM), Endo International Plc (NASDAQ: ENDP), Incyte Corporation (NASDAQ: INCY) and Citrix Systems, Inc. (NASDAQ: CTXS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2197-100free.
Technical Analysis on Active Equities -- Research on Express Scripts Holding, NVIDIA, BroadSoft, and Sysco
PR Newswire - Tue May 06, 8:23AM CDT
The trading session on Monday, May 05, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,530.55, up 0.11% and the NASDAQ Composite closed at 4,138.06, up 0.34%. The S&P 500 finished the day 0.19% higher at 1,884.66. The gains were broad based as eight out of ten sectors finished on a positive note. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Express Scripts Holding Co. (NASDAQ: ESRX), NVIDIA Corp. (NASDAQ: NVDA), BroadSoft Inc. (NASDAQ: BSFT) and Sysco Corp. (NYSE: SYY). Free technical research on ESRX, NVDA, BSFT and SYY can be downloaded upon signing up at:
Walgreen Hits Record Close On Sweet Easter Sales
at Investor's Business Daily - Mon May 05, 3:25PM CDT
Walgreen (WAG) sales climbed 8.8% in April to $5.96 billion as more customers visited stores and spent 6% more per visit. Results also got a lift from a later Easter holiday this year than last, the No. 1 U.S. drug store operator said. Shares of...
Walgreen Shares Climb Sharply in Holiday-Lifted April
at Investor's Business Daily - Mon May 05, 2:10PM CDT
Walgreen (WAG) sales climbed 8.8% in April to $5.96 billion as more customers visited stores and spent 6% more per visit. Results also got a lift from a later Easter holiday this year than last, the company said. Shares of Walgreen, the No. 1 U.S....
Express Scripts to Present at Upcoming Conferences
PR Newswire - Mon May 05, 7:32AM CDT
Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences:
Did This Lightning-Rod Drug Go Too Far?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat May 03, 2:12PM CDT
In this segment from Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass discuss the continuing backlash from pharmacy benefits manager Express Scripts against the price point Gilead has set for its...
Express Scripts Earnings: 3 Things You Need to Know
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
Express Scripts investors had a rough day Tuesday, as a surprised market cut 6% from the company's value after a disappointing first quarter earnings report. There were three huge areas of concern for investors, but first let's talk about the...
Express Scripts (ESRX) Crosses Pivot Point Resistance at $66.84
Comtex SmarTrend(R) - Fri May 02, 9:04AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today above their pivot of $66.34 and have already reached the first level of resistance at $66.84. Analysts will be watching for a cross of the next upside pivot targets of $67.52 and $68.70.
Novo Nordisk lowers outlook
at Investor's Business Daily - Thu May 01, 5:54PM CDT
The diabetes products giant's Q1 EPS was 45 cents, up 10% vs. a year earlier in Danish kroner, beating views by a penny. Sales rose 2% in kroner to the equivalent of $3.73 bil, missing consensus of $3.97 bil. Novo Nordisk (NVO) cut its '14...
Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss
at Investor's Business Daily - Thu May 01, 4:01PM CDT
Danish drug giant Novo Nordisk missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, as the loss of support from U.S. payers hurt. The stock fell 2.9%. Novo Nordisk (NVO) made 45 cents a share in the quarter, up about 10%...
Novo Nordisk Q1 Revenue Misses; Guidance Lowered
at Investor's Business Daily - Thu May 01, 10:48AM CDT
Danish pharmaceutical giant Novo Nordisk (NVO) missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, though profit was in line. Novo stock was down more than 2% in early trading on the stock market today. Novo made 45 cents a...
Downtrend Call Working As Express Scripts Stock Falls 12.6% (ESRX)
Comtex SmarTrend(R) - Thu May 01, 9:30AM CDT
SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on March 27th, 2014 at $75.39. In approximately 1 month, Express Scripts has returned 12.60% as of today's recent price of $65.89.
Will This Price Target Cut Hurt Express Scripts (ESRX) Stock Today?
at The Street - Thu May 01, 8:31AM CDT
Barclays cut its price target for Express Scripts (ESRX) to $83, citing lingering winter weather effects and delays in contract implementation.
Stock Price Updates, Recognitions, Earnings Releases, and Acquisitions of Rights - Analyst Notes on HCA, Express Scripts, Tenet, Quest Diagnostics and Endo
PR Newswire - Thu May 01, 2:53AM CDT
Today, Analysts Review released its analysts' notes regarding HCA Holdings, Inc. (NYSE: HCA), Express Scripts Inc. (NASDAQ: ESRX), Tenet Healthcare Corp. (NYSE: THC), Quest Diagnostics Inc. (NYSE: DGX) and Endo International PLC (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1814-100free.
Why Express Scripts Holding Company, Exelon Corporation, Marathon Oil Corporation Are Today's 3 Wors
John Divine, The Motley Fool - Motley Fool - Wed Apr 30, 7:06PM CDT
First-quarter GDP numbers were released today, and if you didn't know any better you'd think the country was back in recession mode. The U.S. economy grew at just a 0.1% pace in the first quarter, far below the 1.1% economists were expecting. But...
Dow closes at record as Fed keeps cutting stimulus
By STEVE ROTHWELL - AP - Wed Apr 30, 4:19PM CDT
NEW YORK (AP) — The Dow Jones industrial average closed at an all-time high Wednesday as the good narrowly outweighed the bad for the stock market.
Earnings Look Back: Express Scripts Is Down 4.5% Since Reporting Quarterly Results 1 Week Ago (ESRX)
Comtex SmarTrend(R) - Mon May 12, 12:09PM CDT
When Express Scripts (NASDAQ:ESRX) reported earnings 13 days ago on April 29th, 2014, analysts, on average, expected the company to report earnings of $1.00 on sales of $23.8 billion. The company actually reported EPS of $0.99 on sales of $23.7 billion, missing EPS estimates by $0.01 and missing revenue estimates by $140.9 million. Since the company's report, shares of Express Scripts have fallen from $71.01 to $67.80, representing a loss of 4.5% in the past 13 days.
Watch for Express Scripts to Potentially Pullback After Gaining 1.13% Yesterday
Comtex SmarTrend(R) - Fri May 09, 3:52PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $66.71 to a high of $67.85. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.50 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.13% Gain
Comtex SmarTrend(R) - Fri May 09, 3:52PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $66.71 to a high of $67.85. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $67.50 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Critical Alerts For Philip Morris International, Coach, Express Scripts, Staples, and Splunk Released By InvestorsObserver
PR Newswire - Fri May 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PM, COH, ESRX, SPLS, and SPLK.
Earnings Releases, Dividends Announcements, and Product Improvements - Analyst Notes on Express Scripts, Humana, Endo, Incyte and Citrix
PR Newswire - Thu May 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Express Scripts Holding Company (NASDAQ: ESRX), Humana Inc. (NYSE: HUM), Endo International Plc (NASDAQ: ENDP), Incyte Corporation (NASDAQ: INCY) and Citrix Systems, Inc. (NASDAQ: CTXS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2197-100free.
Technical Analysis on Active Equities -- Research on Express Scripts Holding, NVIDIA, BroadSoft, and Sysco
PR Newswire - Tue May 06, 8:23AM CDT
The trading session on Monday, May 05, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,530.55, up 0.11% and the NASDAQ Composite closed at 4,138.06, up 0.34%. The S&P 500 finished the day 0.19% higher at 1,884.66. The gains were broad based as eight out of ten sectors finished on a positive note. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Express Scripts Holding Co. (NASDAQ: ESRX), NVIDIA Corp. (NASDAQ: NVDA), BroadSoft Inc. (NASDAQ: BSFT) and Sysco Corp. (NYSE: SYY). Free technical research on ESRX, NVDA, BSFT and SYY can be downloaded upon signing up at:
Walgreen Hits Record Close On Sweet Easter Sales
at Investor's Business Daily - Mon May 05, 3:25PM CDT
Walgreen (WAG) sales climbed 8.8% in April to $5.96 billion as more customers visited stores and spent 6% more per visit. Results also got a lift from a later Easter holiday this year than last, the No. 1 U.S. drug store operator said. Shares of...
Walgreen Shares Climb Sharply in Holiday-Lifted April
at Investor's Business Daily - Mon May 05, 2:10PM CDT
Walgreen (WAG) sales climbed 8.8% in April to $5.96 billion as more customers visited stores and spent 6% more per visit. Results also got a lift from a later Easter holiday this year than last, the company said. Shares of Walgreen, the No. 1 U.S....
Express Scripts to Present at Upcoming Conferences
PR Newswire - Mon May 05, 7:32AM CDT
Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences:
Did This Lightning-Rod Drug Go Too Far?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat May 03, 2:12PM CDT
In this segment from Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass discuss the continuing backlash from pharmacy benefits manager Express Scripts against the price point Gilead has set for its...
Express Scripts Earnings: 3 Things You Need to Know
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Fri May 02, 1:30PM CDT
Express Scripts investors had a rough day Tuesday, as a surprised market cut 6% from the company's value after a disappointing first quarter earnings report. There were three huge areas of concern for investors, but first let's talk about the...
Express Scripts (ESRX) Crosses Pivot Point Resistance at $66.84
Comtex SmarTrend(R) - Fri May 02, 9:04AM CDT
Shares of Express Scripts (NASDAQ:ESRX) opened today above their pivot of $66.34 and have already reached the first level of resistance at $66.84. Analysts will be watching for a cross of the next upside pivot targets of $67.52 and $68.70.
Novo Nordisk lowers outlook
at Investor's Business Daily - Thu May 01, 5:54PM CDT
The diabetes products giant's Q1 EPS was 45 cents, up 10% vs. a year earlier in Danish kroner, beating views by a penny. Sales rose 2% in kroner to the equivalent of $3.73 bil, missing consensus of $3.97 bil. Novo Nordisk (NVO) cut its '14...
Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss
at Investor's Business Daily - Thu May 01, 4:01PM CDT
Danish drug giant Novo Nordisk missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, as the loss of support from U.S. payers hurt. The stock fell 2.9%. Novo Nordisk (NVO) made 45 cents a share in the quarter, up about 10%...
Novo Nordisk Q1 Revenue Misses; Guidance Lowered
at Investor's Business Daily - Thu May 01, 10:48AM CDT
Danish pharmaceutical giant Novo Nordisk (NVO) missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, though profit was in line. Novo stock was down more than 2% in early trading on the stock market today. Novo made 45 cents a...
Downtrend Call Working As Express Scripts Stock Falls 12.6% (ESRX)
Comtex SmarTrend(R) - Thu May 01, 9:30AM CDT
SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on March 27th, 2014 at $75.39. In approximately 1 month, Express Scripts has returned 12.60% as of today's recent price of $65.89.
Will This Price Target Cut Hurt Express Scripts (ESRX) Stock Today?
at The Street - Thu May 01, 8:31AM CDT
Barclays cut its price target for Express Scripts (ESRX) to $83, citing lingering winter weather effects and delays in contract implementation.
Stock Price Updates, Recognitions, Earnings Releases, and Acquisitions of Rights - Analyst Notes on HCA, Express Scripts, Tenet, Quest Diagnostics and Endo
PR Newswire - Thu May 01, 2:53AM CDT
Today, Analysts Review released its analysts' notes regarding HCA Holdings, Inc. (NYSE: HCA), Express Scripts Inc. (NASDAQ: ESRX), Tenet Healthcare Corp. (NYSE: THC), Quest Diagnostics Inc. (NYSE: DGX) and Endo International PLC (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1814-100free.
Why Express Scripts Holding Company, Exelon Corporation, Marathon Oil Corporation Are Today's 3 Wors
John Divine, The Motley Fool - Motley Fool - Wed Apr 30, 7:06PM CDT
First-quarter GDP numbers were released today, and if you didn't know any better you'd think the country was back in recession mode. The U.S. economy grew at just a 0.1% pace in the first quarter, far below the 1.1% economists were expecting. But...
Dow closes at record as Fed keeps cutting stimulus
By STEVE ROTHWELL - AP - Wed Apr 30, 4:19PM CDT
NEW YORK (AP) — The Dow Jones industrial average closed at an all-time high Wednesday as the good narrowly outweighed the bad for the stock market.
